Literature DB >> 11447727

Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence.

C K Avvad1, R Holeuwerger, V C Silva, M A Bordallo, M M Breitenbach.   

Abstract

We determined the hormonal, metabolic and ultrasonographic pattern of adolescents with menstrual irregularity since menarche but without clinical signs of hyperandrogenism with the aim of evaluating whether this condition represents an early stage of polycystic ovary syndrome (PCOS). These adolescents were divided in two groups: 13 adolescents with irregular cycles (IC) within the first 3 postmenarchal years (IC < or = 3) and 15 adolescents having persistent irregular cycles for more than three postmenarchal years (IC > 3). These adolescents were compared with 15 adolescents with PCOS and 18 normal adolescents. The values of free testosterone, free androgen index, luteinizing hormone (LH) and LH/follicle-stimulating hormone (FSH) ratio were similar in IC < or = 3, IC > 3 and PCOS, and higher than in the normal group (p < 0.005). The total testosterone and androstenedione levels were higher and sex hormone-binding globulin (SHBG) lower in PCOS only when compared with the normal group (p < 0.05). The ovarian volume was similar in IC < or = 3, IC > 3 and PCOS, and higher than in the normal group (p < 0.005). A higher incidence of polycystic structure was found in IC < or = 3, IC > 3 and PCOS, whereas normal structure was more common in normal adolescents (p < 0.0005). There were no significant differences in glucose and insulin parameters between groups. These results indicate that menstrual irregularity within the first postmenarchal years can be an early clinical sign of PCOS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447727

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  8 in total

Review 1.  The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.

Authors:  Robert L Rosenfield
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-08-27       Impact factor: 1.814

2.  The diagnosis of polycystic ovary syndrome in adolescents.

Authors:  Andrea Hsu Roe; Anuja Dokras
Journal:  Rev Obstet Gynecol       Date:  2011

3.  Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.

Authors:  Charles J Glueck; John A Morrison; Stephen Daniels; Ping Wang; Davis Stroop
Journal:  J Pediatr       Date:  2011-03-01       Impact factor: 4.406

Review 4.  Polycystic ovary syndrome in adolescents: current and future treatment options.

Authors:  George Mastorakos; Irene Lambrinoudaki; George Creatsas
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

5.  American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis.

Authors:  Fang-Fang Wang; Jie-Xue Pan; Yan Wu; Yu-Hang Zhu; Paul J Hardiman; Fan Qu
Journal:  J Zhejiang Univ Sci B       Date:  2018-05       Impact factor: 3.066

6.  Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study.

Authors:  John A Morrison; Charles J Glueck; Stephen R Daniels; Paul S Horn; Ping Wang
Journal:  Metabolism       Date:  2012-04-16       Impact factor: 8.694

7.  Polycystic ovary syndrome in university students: occurrence and associated factors.

Authors:  Amita Attlee; Asma Nusralla; Rashida Eqbal; Hanaa Said; Mona Hashim; Reyad Shaker Obaid
Journal:  Int J Fertil Steril       Date:  2014-11-01

Review 8.  Factors Affecting Menstrual Cycle Developmental Trajectory in Adolescents: A Narrative Review.

Authors:  Marzieh Saei Ghare Naz; Maryam Farahmand; Sareh Dashti; Fahimeh Ramezani Tehrani
Journal:  Int J Endocrinol Metab       Date:  2022-03-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.